Form 4: Zoetis CFO Wetteny Reports RSU Vesting, Stock Sales

Zoetis Inc.'s Chief Financial Officer, Joseph Wetteny, reported the routine vesting of restricted stock units and subsequent sale of shares for tax obligations.

Summary

• Joseph Wetteny, Chief Financial Officer of Zoetis Inc., reported transactions involving the company's common stock.
• On February 6, 2026, 1,388 shares of common stock were acquired due to the vesting and settlement of restricted stock units (RSUs).
• Concurrently, 515 shares were disposed of at a price of $127.42 per share to cover tax withholding obligations related to the RSU vesting.
• On February 8, 2026, an additional 1,409 shares of common stock were acquired from the vesting and settlement of other RSUs.
• Another 483 shares were disposed of at a price of $127.42 per share for tax withholding purposes.
• Following these reported transactions, Wetteny directly beneficially owns 20,766 shares of Zoetis Inc. common stock.
• Remaining unvested Restricted Stock Units include 6,152.6517 units granted on February 19, 2025, which are subject to future vesting schedules.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine executive compensation and continued insider ownership, which aligns management interests with shareholders.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates the achievement of performance or service conditions by the Chief Financial Officer.
• The CFO continues to hold a significant number of shares (20,766) directly, aligning his interests with those of shareholders.

Negatives

• A portion of the vested shares (515 shares on February 6, 2026, and 483 shares on February 8, 2026) was sold to cover tax liabilities, which is a common practice but reduces direct ownership.

Future Outlook

Future vesting events for the remaining 6,152.6517 Restricted Stock Units granted on February 19, 2025, are expected to occur on their respective anniversaries, subject to continued service.

Industry Context

StockSavvy.ai notes that routine Form 4 filings, such as this one, provide transparency into insider ownership and compensation structures. While not indicative of a change in company fundamentals, they confirm that executive compensation plans, including RSU vesting, are proceeding as scheduled within the pharmaceutical and animal health sectors.

Stakeholder Impact

• Shareholders: The CFO's continued beneficial ownership of 20,766 shares aligns his interests with those of shareholders. The RSU vesting is part of a pre-approved compensation plan.
• Employees: The RSU vesting demonstrates the company's commitment to its equity incentive plan for key personnel.

Next Steps

• Future vesting of the remaining 6,152.6517 Restricted Stock Units granted on February 19, 2025, on their first, second, and third anniversaries, subject to continued service.

Key Dates

Keywords

Zoetis, ZTS, Joseph Wetteny, CFO, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Stock Sale, Tax Withholding, Beneficial Ownership